Drugs Health Pharma

Israel’s Teva gets FDA nod for treating schizophrenia in adult patients

HQ Team October 10, 2026: Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved.

Read More
Climate Health

Study finds link between urban design and depression risk

"Social interactions create a sense of community, reciprocity, and trustworthiness, which are factors positively related to mental well-being and protective against depression."

Read More